Robert A. Baffi
2020
Compensation breakdown
Non-Equity Incentive Plan | $443,300 |
---|---|
Option Awards | $810,197 |
Salary | $637,115 |
Stock Awards | $2,769,042 |
Other | $29,047 |
Total | $4,688,701 |
Baffi received $2.8M in stock awards, accounting for 59% of the total pay in 2020.
Baffi also received $443.3K in non-equity incentive plan, $810.2K in option awards, $637.1K in salary and $29K in other compensation.
Rankings
In 2020, Robert A. Baffi's compensation ranked 2,376th out of 13,090 executives tracked by ExecPay. In other words, Baffi earned more than 81.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,376 | 82nd |
Manufacturing | 911 | 84th |
Chemicals And Allied Products | 324 | 86th |
Drugs | 275 | 86th |
Pharmaceutical Preparations | 197 | 87th |
Pay ratio
Robert A. Baffi's Pay | $4,688,701 |
---|---|
Median Employee's Pay | $181,141 |
Pay Ratio | 26to 1 |
In 2020, the annual total compensation of Robert A. Baffi was $4,688,701.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.
The ratio of Robert A. Baffi's pay to the pay of median employee was therefore 26 to one.
Baffi's colleagues
We found six more compensation records of executives who worked with Robert A. Baffi at BioMarin Pharmaceutical in 2020.
2020
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2020
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2020
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2020
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
2020
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2020
Daniel Spiegelman
BioMarin Pharmaceutical